Sharp Therapeutics Corp.
SHRX.V
TSX
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 233.90K | 376.90K | 376.90K | 376.90K | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 40.50K | -- | 48.80K | 48.80K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.50K | -- | -- | -- | -- |
| Total Current Assets | 303.90K | -- | 425.60K | 425.60K | -- |
|
|
|||||
| Total Current Assets | 303.90K | -- | 425.60K | 425.60K | -- |
| Net Property, Plant & Equipment | 1.07M | -- | 1.10M | 1.10M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.70K | -- | 16.70K | 16.70K | -- |
| Total Assets | 1.39M | -- | 1.55M | 1.55M | -- |
|
|
|||||
| Total Accounts Payable | 430.90K | -- | 184.60K | 184.60K | -- |
| Total Accrued Expenses | 427.30K | -- | 227.10K | 227.10K | -- |
| Short-term Debt | 13.70M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 31.00K | -- | 7.31M | 7.31M | -- |
| Total Finance Division Other Current Liabilities | 16.50K | -- | -- | -- | -- |
| Total Other Current Liabilities | 16.50K | -- | -- | -- | -- |
| Total Current Liabilities | 14.60M | -- | 7.72M | 7.72M | -- |
|
|
|||||
| Total Current Liabilities | 14.60M | -- | 7.72M | 7.72M | -- |
| Long-Term Debt | -- | -- | 3.97M | 3.97M | -- |
| Short-term Debt | 13.70M | -- | -- | -- | -- |
| Capital Leases | 1.30M | -- | 1.32M | 1.32M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 19.40K | 19.40K | -- |
| Total Liabilities | 15.90M | -- | 13.03M | 13.03M | -- |
|
|
|||||
| Common Stock & APIC | 5.15M | -- | 5.14M | 5.14M | -- |
| Retained Earnings | -19.66M | -- | -16.62M | -16.62M | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -14.51M | -11.48M | -11.48M | -11.48M | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.51M | -11.48M | -11.48M | -11.48M | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.51M | -11.48M | -11.48M | -11.48M | -- |
|
|
|||||